These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38027112)

  • 21. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder.
    Hantsoo L; Grillon C; Sammel M; Johnson R; Marks J; Epperson CN
    Psychopharmacology (Berl); 2021 Oct; 238(10):2985-2997. PubMed ID: 34292344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stress and rumination in Premenstrual Syndrome (PMS): Identifying stable and menstrual cycle-related differences in PMS symptom severity.
    Kappen M; Raeymakers S; Weyers S; Vanderhasselt MA
    J Affect Disord; 2022 Dec; 319():580-588. PubMed ID: 36162688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.
    Epperson CN; Pittman B; Czarkowski KA; Stiklus S; Krystal JH; Grillon C
    Neuropsychopharmacology; 2007 Oct; 32(10):2190-8. PubMed ID: 17314917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and correlates of premenstrual syndrome and premenstrual dysphoric disorder among women aged 18-25 in Turkey.
    Turan A; Güler Kaya İ; Çakır HB; Topaloğlu S
    Int J Psychiatry Med; 2024 Jan; 59(1):101-111. PubMed ID: 37448169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention, response inhibition, impulsivity, and decision-making within luteal phase in women with premenstrual dysphoric disorder.
    Yen JY; Lin PC; Hsu CJ; Lin C; Chen IJ; Ko CH
    Arch Womens Ment Health; 2023 Jun; 26(3):321-330. PubMed ID: 37010619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 31. No Menstrual Cyclicity in Mood and Interpersonal Behaviour in Nine Women with Self-Reported Premenstrual Syndrome.
    Bosman RC; Albers CJ; de Jong J; Batalas N; Aan Het Rot M
    Psychopathology; 2018; 51(4):290-294. PubMed ID: 29874668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premenstrual appetite and emotional responses to foods among women with premenstrual dysphoric disorder.
    Yen JY; Liu TL; Chen IJ; Chen SY; Ko CH
    Appetite; 2018 Jun; 125():18-23. PubMed ID: 29407746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daily symptom ratings for studying premenstrual dysphoric disorder: A review.
    Bosman RC; Jung SE; Miloserdov K; Schoevers RA; aan het Rot M
    J Affect Disord; 2016 Jan; 189():43-53. PubMed ID: 26406968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder.
    Gingnell M; Morell A; Bannbers E; Wikström J; Sundström Poromaa I
    Horm Behav; 2012 Sep; 62(4):400-6. PubMed ID: 22814368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls.
    Girdler SS; Sherwood A; Hinderliter AL; Leserman J; Costello NL; Straneva PA; Pedersen CA; Light KC
    Psychosom Med; 2003; 65(5):849-56. PubMed ID: 14508031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lack of consistent evidence for cortisol dysregulation in premenstrual syndrome/premenstrual dysphoric disorder.
    Kiesner J; Granger DA
    Psychoneuroendocrinology; 2016 Mar; 65():149-64. PubMed ID: 26789492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
    Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
    Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
    Yang J; Joe SH; Lee MS; Kim SH; Jung IK
    Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.